RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Content

Elyshev Vladimir Gennadyevich
Elyshev Vladimir Gennadyevich

Biography

2022: Dismissal from Sverdlovsk Cancer Dispensary

January 12, 2022 it became known about the dismissal of the chief physician of the Sverdlovsk Regional Oncological Dispensary Vladimir Elyshev. This was reported in the regional Ministry of Health. At the same time, the department did not name the reasons for the dismissal of the head of the medical institution. It also does not say who will replace him.

By January 12, 2022, an unscheduled check organized by the Sverdlovsk Ministry of Finance is taking place in the oncological dispensary. According to the EAN, the claims are related to public procurement. So violations were revealed when buying a coagulator, tomograph, ultrasound apparatus and anesthesia-respiratory apparatus. Errors were detected during equipment reception.

In addition, auditors found the absence of a number of reporting documents. So, there was no order to increase the value of one of the contracts from 37 to 48 million rubles.

The source of the publication noted that the deputy minister of health of the Sverdlovsk region, the former head of the city health of Yekaterinburg Denis Demidov may become the new head of the Sverdlovsk Oncological Dispensary.

According to Znak.com, employees and patients of the oncological dispensary opposed the dismissal of the head physician. They wrote a letter to the head of the region, Yevgeny Kuyvashev, the message was signed by more than 100 people. Applicants note that after the arrival of Vladimir Elyshev, the oncological dispensary "began to blossom":

File:Aquote1.png
New equipment has appeared, technologies that we have seen only in federal centers. Thanks to this, our patients began to be treated more often at home in the Sverdlovsk region. And we, the doctors, have the opportunity to fight even the most complex localizations of tumors that could not be treated before, the letter says.
File:Aquote2.png

Doctors called Elyshev "flagship" and announced their desire to continue to develop and not lower the bar, the publication reports.[1][2]

Notes